Matthew Dowdy
Psychiatric/Mental Health · Woodstock, GANPI 1295382125
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,413 of the $25,126 with a category attached, or 73.3%. Axsome Therapeutics, Inc. accounts for 72.8% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $21,896, more than ten times the $1,048 reported in 2021. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $104.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$18K
- AbbVie$5K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$273
- Bausch Health US, LLC$166
- Takeda Pharmaceuticals U.S.A., Inc.$158
- Braeburn Inc.$145
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$18,41373%
- Travel & lodging$2,67011%
- Food & beverage$3,99616%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 57 | $18,289 |
| AbbVie | 89 | $5,015 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $273 |
| Bausch Health US, LLC | 14 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $158 |
| Braeburn Inc. | 1 | $145 |
| Otsuka America Pharmaceutical, Inc. | 8 | $126 |
| Alkermes, Inc. | 5 | $123 |
| Lundbeck LLC | 7 | $121 |
| Corium, LLC | 4 | $115 |
| Jazz Pharmaceuticals Inc. | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| Indivior Inc. | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $69 |
| USWM, LLC | 2 | $58 |
| Neos Therapeutics, LP | 3 | $51 |
| Ironshore Pharmaceuticals Inc. | 2 | $39 |
| Merck | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,126 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $208 |
| Lorazepam | 11 | $124 |
| Clonazepam | 19 | $77 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Woodstock
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
- Mia MisonSuwanee$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.